PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 11, 2026New England Journal of Medicine3 citations

Celiac Disease

View Full Paper
JMJ. Lee MurraySHSteffen Husby

Key Points

  • To explore the diagnosis and treatment strategies for celiac disease along with its associated risks.
  • Evaluated serologic tests for IgA antibodies against tissue transglutaminase.
  • Considered endomysial antibody tests and duodenal biopsies as diagnostic tools.
  • Assessed the role of HLA-DQ2 and HLA-DQ8 genes in disease predisposition.
  • Reviewed management approaches, particularly the gluten-free diet.
  • Diagnosis of celiac disease commonly relies on serologic testing.
  • HLA-DQ2 or HLA-DQ8 gene presence is essential for developing the disease.
  • Nonresponsive celiac disease is linked to increased risks of malignancy.
  • Celiac disease often exists alongside other autoimmune diseases, like type 1 diabetes.

Abstract

Celiac disease, a common autoimmune condition affecting approximately 1% of the population, can develop with exposure to gluten at any age. Diagnosis involves serologic testing, especially for IgA antibodies against tissue transglutaminase, and may include tests to confirm the presence of endomysial antibodies or even duodenal biopsies, although the latter are becoming less necessary. The presence of genes encoding HLA-DQ2 or HLA-DQ8 is a prerequisite for the disease. A gluten-free diet is the mainstay of treatment, but some adults have nonresponsive celiac disease, which warrants closer monitoring because of an increased risk of malignant conditions. Celiac disease also frequently co-occurs with other autoimmune disorders, such as type 1 diabetes mellitus and autoimmune thyroid disease.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Murray et al. (2026) studied this question.

synapsesocial.com/papers/69d9e47378050d08c1b75160https://doi.org/10.1056/nejmcp2415548
Ask AI
Helpful
Bookmark
Share
View Full Paper